RK

Rakesh Kadam

Director Director DIN 02055328
DIN 02055328 First appointment Feb 2008 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Feb 2008
Shareholding value Locked Premium profile

About Rakesh Kadam

Data last updated:

Rakesh Kadam has 18 years in corporate governance. Formerly with 1 company, such as Loguss Pharma Chem Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 02055328
Primary Designation Director
First Appointment 25 Feb 2008
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Loguss Pharma Chem Private Limited U24100MH1999PTC120646
Director25 Feb 20081999Converted To Llp

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Loguss Pharma Chem Private Limited
Premium access

Shareholding and investment profile for Rakesh Kadam

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rakesh Kadam

Rakesh Kadam has 18 years in corporate governance. Formerly with 1 company, such as Loguss Pharma Chem Private Limited. Engaged in General Business. Contributes to corporate operations.

Rakesh Kadam is associated with 0 companies as a director.

Rakesh Kadam has expertise in General Business.

Rakesh Kadam has 18 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available